Medicare Enrolled
Dr. Shannon Comley Sood, D.O.
Endocrinology · Schenectady, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Comley Sood from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Comley Sood?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Comley Sood
Dr. Shannon Comley Sood is an endocrinology specialist in Schenectady, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Comley Sood performed 1,066 Medicare services across 688 unique beneficiaries.
Between the years covered by Open Payments, Dr. Comley Sood received a total of $7,784 from 50 pharmaceutical and/or device companies across 374 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Comley Sood is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 39% volume in NY
$7,784 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,066
Medicare services
Top 39% in NY for endocrinology
688
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~56 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
290 | $93 | $236 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
184 | $9 | $26 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
183 | $3 | $6 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
115 | $8 | $15 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
69 | $26 | $87 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
55 | $61 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $57 | $173 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $118 | $367 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
30 | $47 | $106 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
21 | $11 | $49 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $134 | $456 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
20 | $37 | $89 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,784
Total received (2018-2024)
Avg $1,112/year across 7 years
Top 25% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
374
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,784 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,738
2023
$2,010
2022
$1,468
2021
$1,121
2020
$378
2019
$694
2018
$374
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$190
Dexcom, Inc.
$186
Medtronic, Inc.
$180
Xeris Pharmaceuticals, Inc.
$168
Abbott Laboratories
$154
BETA BIONICS, INC.
$101
Amgen Inc.
$86
SANOFI-AVENTIS U.S. LLC
$85
RECORDATI_RARE_DISEASES_INC.
$71
Alexion Pharmaceuticals, Inc.
$69
Ascensia Diabetes Care Us Inc.
$65
Novartis Pharmaceuticals Corporation
$62
Novo Nordisk Inc
$51
Ascendis Pharma Inc
$47
Insulet Corporation
$41
IBSA Pharma Inc.
$35
Antares Pharma, Inc.
$34
ABBVIE INC.
$34
Tandem Diabetes Care, Inc.
$29
RGH Enterprises LLC
$18
Renalytix AI, Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Top 3 companies account for 32.0% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$812
Novo Nordisk Inc
$752
Dexcom, Inc.
$651
Amgen Inc.
$540
Abbott Laboratories
$502
Insulet Corporation
$483
SANOFI-AVENTIS U.S. LLC
$449
Antares Pharma, Inc.
$308
Medtronic, Inc.
$288
Corcept Therapeutics
$267
Xeris Pharmaceuticals, Inc.
$208
Tandem Diabetes Care, Inc.
$193
Boehringer Ingelheim Pharmaceuticals, Inc.
$188
RECORDATI_RARE_DISEASES_INC.
$183
AstraZeneca Pharmaceuticals LP
$168
MannKind Corporation
$149
IBSA Pharma Inc.
$129
Amneal Pharmaceuticals LLC
$127
BETA BIONICS, INC.
$101
Alexion Pharmaceuticals, Inc.
$89
Ascensia Diabetes Care Us Inc.
$85
Novartis Pharmaceuticals Corporation
$75
AbbVie Inc.
$71
ABBVIE INC.
$71
Supernus Pharmaceuticals, Inc.
$67
Mannkind Corporation
$65
Renalytix AI, Inc.
$62
Embecta Corp.
$61
Bayer Healthcare Pharmaceuticals Inc.
$59
Radius Health, Inc.
$54
Merck Sharp & Dohme LLC
$53
Ascendis Pharma Inc
$47
Intuity Medical Inc
$39
Bayer HealthCare Pharmaceuticals Inc.
$38
DEXCOM, INC.
$36
Horizon Therapeutics plc
$35
Janssen Pharmaceuticals, Inc
$28
PFIZER INC.
$27
Rhythm Pharmaceuticals, Inc.
$25
Shire North American Group Inc
$24
Senseonics, Incorporated
$23
EUSA Pharma (US) LLC
$21
Merck Sharp & Dohme Corporation
$19
Becton, Dickinson and Company
$18
RGH Enterprises LLC
$18
Ultragenyx Pharmaceutical Inc.
$16
LifeScan, Inc.
$16
EISAI INC.
$16
CeQur Corporation
$15
Currax Pharmaceuticals LLC
$13
Top 3 companies account for 28.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano 2nd Gen Pen Needle · Belviq · CONTRAVE · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FIASP · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · HUMULIN · INVOKANA · ISTURISA · JANUVIA · JARDIANCE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LEQVIO · LICART · MINIMED 780G · MOUNJARO · Minimed 670G System · NATPARA (PARATHYROID HORMONE) · NOCDURNA · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnipod · Ozempic · Pogo Automatic Blood Glucose Monitoring System · Prolia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Sylvant · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Tirosint · Tymlos · UNITHROID · Victoza · Wegovy · XYOSTED · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
33
Per 100K population
20.7
County median income
$76,989
Nearest hospital
ELLIS HOSPITAL
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Comley Sood is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Comley Sood experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Comley Sood performed 290 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Comley Sood receive payments from pharmaceutical companies?
Yes. Dr. Comley Sood received a total of $7,784 from 50 companies across 374 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Comley Sood's costs compare to other endocrinologists in Schenectady?
Dr. Comley Sood's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Comley Sood) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Schenectady
Browse endocrinologists in Schenectady ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NY
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NY
Which NY endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Dexcom, Inc. Payments to Doctors
See all physicians who received payments from Dexcom, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology